Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure 3 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
  1. Home
  2. Publications
  3. Figure 3 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Figure 3 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors

Authors:
  • OHOmid Hamid
    Omid Hamid
  • DCDana B. Cardin
    Dana B. Cardin
  • FHF. Stephen Hodi
    F. Stephen Hodi
  • PLPatricia LoRusso
    Patricia LoRusso
  • TMTaha Merghoub
    Taha Merghoub
  • RZRoberta Zappasodi
    Roberta Zappasodi
  • RMRachana Maniyar
    Rachana Maniyar
  • JJJohn E. Janik
    John E. Janik
  • MVMaikel V.W. van der Velden
    Maikel V.W. van der Velden
  • FZFeng Zhou
    Feng Zhou
  • ZDZhiwan Dong
    Zhiwan Dong
  • XCXuejun Chen
    Xuejun Chen

Open Access
Publisher website
Google Scholar
  • 1 October 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30255716
Abstract
A, Frequencies of Tregs. B, Changes in central memory (CM) and EM CD4+ T cells.
Keywords
  • RECEPTOR AGONIST
  • NECROSIS FACTOR
  • FACTOR RECEPTOR
  • METASTATIC SOLID
  • TUMOR NECROSIS
  • SOLID TUMORS
  • GLUCOCORTICOID-INDUCED TUMOR
  • FIGURE
  • PHASE
  • AGONIST
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.